(Q52511479)

2 May 2018

title

D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. (English)

1 reference

2 May 2018

0 references

D C Hoffman

1

1 reference

2 May 2018

H Donovan

series ordinal

2

1 reference

2 May 2018

publication date

1 August 1994

1 reference

2 May 2018

published in

Psychopharmacology

1 reference

2 May 2018

volume

115

1 reference

2 May 2018

page(s)

447-453

1 reference

2 May 2018

issue

4

1 reference

2 May 2018

https://scigraph.springernature.com/pub.10.1007/bf02245567

exact match

0 references

cites work

Gating and habituation of the startle reflex in schizophrenic patients

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245567

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245567

A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

21 January 2018

1 reference

12 December 2020

Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats

1 reference

12 December 2020

Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input

1 reference

12 December 2020

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

12 December 2020

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

12 December 2020

Dose and time response analysis of apomorphine's effect on prepulse inhibition of acoustic startle

1 reference

12 December 2020

Startle gating deficits occur across prepulse intensities in schizophrenic patients

1 reference

12 December 2020

Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains.

1 reference

12 December 2020

Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex.

1 reference

12 December 2020

The design and calibration of a startle measurement system

1 reference

12 December 2020

Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat

1 reference

12 December 2020

Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4

1 reference

12 December 2020

Effects of various direct or indirect dopamine agonists on the latency of the acoustic startle response in rats

1 reference

12 December 2020

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

1 reference

12 December 2020

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

12 December 2020

Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats

1 reference

12 December 2020

Effects of apomorphine and haloperidol on the acoustic startle response in rats

1 reference

12 December 2020

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

12 December 2020

Animal models with construct validity for schizophrenia.

1 reference

12 December 2020

Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens.

1 reference

12 December 2020

New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245567

1 reference

2 May 2018

PubMed ID

7871088

1 reference

2 May 2018